Additional file 6 of DNA methylation epi-signature is associated with two molecularly and phenotypically distinct clinical subtypes of Phelan-McDermid syndrome
Description
Additional file 6: Table S5. Statistical comparison of metabolite profiles. Results of the statistical comparisons for metabolite levels comparing control lymphoblastoid cell lines (LCLs) to the cell lines from individuals with small 22q13 deletions (
Publication Date
1-1-2021
Publisher
figshare Academic Research System
DOI
10.6084/m9.figshare.13533187.v1
Document Type
Data Set
Recommended Citation
Cappuccio, G.; Schwartz, C.E.; Sarasua, S.M.; DuPont, B.; Aref-Eshghi, E.; Levy, M.A.; Rogers, R.C.; Brunetti-Pierri, N.; Jain, L.; Phelan, K.; Sadikovic, B.; Kerkhof, J.; Schenkel, L.C.; Boccuto, L.; Rooney, K.; McConkey, H.; Pauly, R. (2021), "Additional file 6 of DNA methylation epi-signature is associated with two molecularly and phenotypically distinct clinical subtypes of Phelan-McDermid syndrome", figshare Academic Research System, doi: 10.6084/m9.figshare.13533187.v1
https://doi.org/10.6084/m9.figshare.13533187.v1
Identifier
10.6084/m9.figshare.13533187.v1
Embargo Date
1-1-2021